Rare Ovarian Cancer Precision QOL Trial
March 13, 2013
Location: The Hospital of Central Connecticut
Patient REported Symptoms In OvariaN Cancer (Precision) A multicenter, observational, prospective study of high-risk first-line and second-line platinum-sensitive ovarian cancer
patients.